Cite
HARVARD Citation
Kavanaugh, A. et al. (n.d.). SAT0122 Efficacy of addition, or continuation, of adalimumab in patients who did not achieve stable low disease activity with methotrexate or adalimumab plus methotrexate in the optima study. Annals of the rheumatic diseases. pp. 511-512. [Online].